Regulus Therapeutics (RGLS) Fails to deliver data

Key failure to deliver metrics for Regulus Therapeutics:

• Last SEC data release: 2024-11-29
• Last 15 days FTD volume: €0.02 M
• Last 3 months FTD volume: €0.78 M
• Last year FTD volume: €0.78 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regulus Therapeutics (RGLS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regulus Therapeutics (RGLS) - since 2022

Regulus Therapeutics (RGLS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
GlaxoSmithKline GSK	€57.35 M	€99.79 M	🇬🇧 UK
Sanofi SNY	€11.17 M	€72.51 M	🇫🇷 France
Biogen BIIB	€24.41 M	€68.86 M	🇺🇸 USA
AstraZeneca AZN	€68.08 M	€0.19 B	🇬🇧 UK
Alnylam Pharmaceuticals ALNY	€10.32 M	€39.54 M	🇺🇸 USA
Sangamo Therapeutics SGMO	€3.12 M	€5.28 M	🇺🇸 USA
Bristol-Myers Squibb BMY	€43.55 M	€0.32 B	🇺🇸 USA